Vaccination against COVID-19 and allergy (literature review)

Рафаил Розенсон, Alina Tyo, M. E. Abdyrasylov

2021

Closed access Metadata (CSL-JSON)
DOI 10.33920/med-12-2112-07
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The coronavirus pandemic is the most global crisis of our time, therefore, worldwide vaccination against COVID-19 plays a key role in keeping the current situation under control. Numerous studies show that, despite the existing cases of adverse allergic reactions, people with allergic pathology are recommended to complete the full course of vaccination against COVID-19. COVID-19 vaccines have been approved for emergency use during the pandemic and have long-term effectiveness, including for those with allergies.